CompuGroup Medical Forecast, price target & analysts
CompuGroup Medical Target price 2025 - Analyst rating & recommendation
CompuGroup Medical Classifications & Recommendation:
CompuGroup Medical Price Target
| Target Price | €23.40 |
| Price | €22.10 |
| Potential |
5.88%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target CompuGroup Medical 2026 .
The average CompuGroup Medical target price is €23.40.
This is
5.88%
register free of charge
€29.00
31.22%
register free of charge
€22.00
0.45%
register free of charge
|
|
| A rating was issued by 5 analysts: 1 Analysts recommend CompuGroup Medical to buy, 3 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CompuGroup Medical stock has an average upside potential 2026 of
5.88%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion € | 1.19 | 1.16 |
| 5.13% | 2.16% | |
| EBITDA Margin | 22.81% | 19.66% |
| 7.86% | 13.83% | |
| Net Margin | 3.83% | 4.57% |
| 40.63% | 19.21% |
9 Analysts have issued a sales forecast CompuGroup Medical 2024 . The average CompuGroup Medical sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an CompuGroup Medical EBITDA forecast 2024. The average CompuGroup Medical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 CompuGroup Medical Analysts have issued a net profit forecast 2024. The average CompuGroup Medical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.88 | 1.03 |
| 37.59% | 17.05% | |
| P/E | 21.92 | |
| EV/Sales | 1.67 |
8 Analysts have issued a CompuGroup Medical forecast for earnings per share. The average CompuGroup Medical EPS is
This results in the following potential growth metrics and future valuations:
CompuGroup Medical...
Current CompuGroup Medical Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Dec 09 2024 |
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Dec 09 2024 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Dec 08 2024 |
| WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Dec 08 2024 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Nov 27 2024 |
| BNP PARIBAS EXANE |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
| LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Nov 10 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Dec 09 2024 |
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Dec 09 2024 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Dec 08 2024 |
|
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Dec 08 2024 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Nov 27 2024 |
|
Locked
BNP PARIBAS EXANE:
Locked
➜
Locked
|
Nov 13 2024 |
|
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Nov 10 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
